QA1.790BillableNon-CCNew for FY2027POA Exempt

Familial cancer syndrome with pathogenic BRCA1 mutation

Congenital Malformations, Deformations and Chromosomal Abnormalities·Other inherited neoplasm predisposition syndrome of multiple systems·subcategory·FY 2027

Also indexed as: Syndrome, BRCA1-cancer predisposition; Syndrome, familial cancer, with, pathogenic BRCA1 mutation; Syndrome, hereditary breast and ovarian cancer, with, pathogenic BRCA1 mutation

Instructional notes

Includes: conditions that are coded here

  • BRCA1-cancer predisposition syndrome
  • Hereditary breast and ovarian cancer syndrome with pathogenic BRCA1 mutation

Also applies, from QA1: Genetic disorders associated with neoplasms, not elsewhere classified

These notes sit on QA1 and apply to every code under it, including QA1.790.

Excludes2: not included here, code separately if applicable

  • multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Code also: add a code for this too, order depends on the encounter

  • if applicable, any associated conditions, such as:
  • genetic susceptibility to malignant neoplasm by site (Z15.0-)
  • malignant neoplasms (C00.0-C96.9)
  • personal history of malignant neoplasm (Z85.-)

MS-DRGs

As the principal diagnosis, this code groups to these MS-DRGs (v44.0).

Code history

  • FY 2026: replaced Z15.09 (Genetic susceptibility to other malignant neoplasm)